Randomised double blind placebo controlled trial of oral lisdexamfetamine for methamphetamine withdrawal

  • Ezard, Nadine (Primary Chief Investigator (PCI))
  • Siefried, Krista (Chief Investigator (CI))
  • Dunlop, Adrian John (Chief Investigator (CI))
  • Lintzeris, Nicholas (Chief Investigator (CI))
  • Shoptaw, Steven (Chief Investigator (CI))
  • Haber, Paul Steven (Chief Investigator (CI))
  • Carr, Andrew D. (Chief Investigator (CI))
  • Doyle, Michael Francis (Chief Investigator (CI))
  • Arunogiri, Shalini (Chief Investigator (CI))
  • Clifford, Michael (Chief Investigator (CI))
  • Levin, Frances (Associate Investigator (AI))
  • Bonomo, Yvonne Ann (Associate Investigator (AI))
  • Lubman, Dan (Associate Investigator (AI))
  • Nagle, Jack (Associate Investigator (AI))
  • Cox, Duran (Associate Investigator (AI))
  • Moller, Carl (Associate Investigator (AI))
  • Christmass, Michael (Associate Investigator (AI))
  • Acheson, Liam (Associate Investigator (AI))
  • McKetin, Rebecca (Associate Investigator (AI))
  • Donoghoe, Mark W. (Associate Investigator (AI))
  • Kuner, Imogen (Project Manager)
  • Logan, Ian (Project Manager)

Project: Research

Project Details

Short titleOLAM
AcronymOLAM
StatusActive
Effective start/end date1/09/24 → 30/06/27